Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic

Updated 05/28/2024

Status Recruiting

Clinical Trial Summary

The objectives of this phase Ib study are to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenic profiles of B001 in subjects with aquaporin-4 antibody (AQP4-IgG) positive NMOSD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05145361
Study type	Interventional
Source	Shanghai Pharmaceuticals Holding Co., Ltd
Contact	Fu-Dong Shi, MD,PhD
Phone	022-60814587
Email	Shifudong219@163.com
Status	Recruiting
Phase	Early Phase 1
Start date	April 7, 2022
Completion date	December 15, 2024

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05154734` - Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders	Phase 1/Phase 2
	Withdrawn	`NCT03829566` - Autologous Transplant To End NMO Spectrum Disorder	Phase 2/Phase 3
	Recruiting	`NCT05403138` - Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
	Completed	`NCT05432713` - A Study of LP-168 in Healthy Volunteers	Phase 1
	Not yet recruiting	`NCT04822623` - Imaging Evaluation of Central Nervous Autoimmune Diseases
	Completed	`NCT04227470` - A Study of HBM9161 in NMOSD Patients	Phase 1
	Not yet recruiting	`NCT06280755` - Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
	Recruiting	`NCT05414890` - Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination
	Recruiting	`NCT05840055` - ACT With NMOSD Patients and Caregivers Pilot Study	N/A
	Recruiting	`NCT05004493` - Biorepository and Registry for Plasma Exchange Patients
	Completed	`NCT05896605` - Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder	Phase 4
	Recruiting	`NCT04106830` - Clinical and Imaging Patterns of Neuroinflammation Diseases in China (CLUE)
	Completed	`NCT03766347` - Pediatric NMOSD Observational Study
	Recruiting	`NCT05154370` - China National Registry of Neuro-Inflammatory Diseases
	Not yet recruiting	`NCT05974293` - A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders	Phase 2
	Completed	`NCT04355611` - Epidemiological Characteristics of COVID-19 in Patients With MS or NMO
	Recruiting	`NCT05792462` - Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders	Phase 1/Phase 2